Camp4 Therapeutics Corp (CAMP)

Latest Insider Confidence Score

2025Q4

58.0
Bullish

Company insider confidence (by quarter)

2024Q4 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Enavate Sciences GP, LLC 10% Owner 2,422,166 Oct 17, 2024
Everest Aggregator, LP 10% Owner 2,422,166 Oct 17, 2024
Northpond Ventures II GP, LLC 10% Owner 471,415 Oct 17, 2024
Northpond Ventures II, LP 10% Owner 471,415 Oct 17, 2024
Northpond Ventures GP, LLC 10% Owner 471,415 Oct 17, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 11, 2025 Dec 22, 2025 Tardiff Daniel Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 11, 2025 Dec 22, 2025 Maricich Yuri Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 11, 2025 Dec 22, 2025 Gold Kelly CFO Neutral 52.5 - 0.00% ✗ -
Dec 11, 2025 Dec 22, 2025 Mandel-Brehm Josh CEO Neutral 52.5 - 0.00% ✗ -
Oct 10, 2025 Tardiff Daniel Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Sep 11, 2025 Sep 15, 2025 Schwab Andrew J. Director Neutral 90.0 +2,941,176 100.45% ✗ -
Sep 11, 2025 Sep 15, 2025 5AM Partners VI, LLC 10% Owner Buy 100.0 +2,941,176 100.45% ✗ $4.5M
Sep 11, 2025 Sep 11, 2025 Polaris Management Co. VII, L.L.C. 10% Owner Buy 100.0 +1,307,189 76.18% ✗ $2M
Sep 11, 2025 Sep 11, 2025 Nashat Amir Director Buy 100.0 +1,307,189 76.18% ✗ $2M
Sep 11, 2025 Sep 11, 2025 Maricich Yuri Chief Medical Officer Buy 90.0 +6,060 100.00% ✗ $10K
Sep 11, 2025 Sep 11, 2025 Gold Kelly CFO Buy 85.0 +6,060 9.80% ✗ $10K
Sep 11, 2025 Sep 11, 2025 Mandel-Brehm Josh CEO Buy 77.5 +6,060 2.23% ✗ $10K
Sep 11, 2025 Sep 11, 2025 Young Richard A Director Buy 86.3 +15,151 9.78% ✗ $25K
Jun 25, 2025 Jun 27, 2025 Boylan James P Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Young Richard A Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Higgins Michael J Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Schwab Andrew J. Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Holtzman Steven H Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Nashat Amir Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Thadhani Ravi I. Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Ragan Paula Director Neutral 52.5 - 0.00% ✗ -
Apr 11, 2025 WILLIAMS DOUGLAS E Director Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 3, 2025 Bumcrot David Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 3, 2025 Maricich Yuri Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 3, 2025 Gold Kelly CFO Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 3, 2025 Mandel-Brehm Josh CEO Neutral 52.5 - 0.00% ✗ -
Mar 17, 2025 Mar 19, 2025 WILLIAMS DOUGLAS E Director Neutral 52.5 - 0.00% ✗ -
Mar 17, 2025 Mar 19, 2025 Stewart Murray Director Neutral 52.5 - 0.00% ✗ -
Mar 19, 2025 WILLIAMS DOUGLAS E Director Neutral 52.5 - 0.00% ✗ -
Mar 19, 2025 Stewart Murray Director Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Oct 22, 2024 Polaris Management Co. VII, L.L.C. 10% Owner Buy 100.0 +909,090 100.00% ✗ $10M
Oct 22, 2024 Polaris Partners GP X, L.L.C. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Oct 17, 2024 Northpond Ventures II GP, LLC 10% Owner Buy 100.0 +763,636 100.00% ✗ $8.4M
Oct 15, 2024 Oct 17, 2024 AH Equity Partners Bio I, L.L.C. 10% Owner Buy 100.0 +727,272 52.02% ✗ $8M
Oct 15, 2024 Oct 17, 2024 Enavate Sciences GP, LLC 10% Owner Buy 100.0 +1,363,636 56.30% ✗ $15M
Oct 15, 2024 Oct 15, 2024 Polaris Management Co. VII, L.L.C. 10% Owner Buy 100.0 +909,090 100.00% ✗ $10M
Oct 15, 2024 Oct 15, 2024 5AM Partners VI, LLC 10% Owner Buy 100.0 +909,090 52.98% ✗ $10M
Oct 15, 2024 Oct 15, 2024 Nashat Amir Director Buy 100.0 +909,090 100.00% ✗ $10M
Oct 15, 2024 Oct 15, 2024 Schwab Andrew J. Director Buy 100.0 +909,090 52.98% ✗ $10M
Oct 15, 2024 Oct 15, 2024 Holtzman Steven H Director Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Oct 15, 2024 Young Richard A Director Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Oct 15, 2024 Mandel-Brehm Josh CEO Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Polaris Partners GP X, L.L.C. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Polaris Management Co. VII, L.L.C. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Enavate Sciences GP, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Northpond Ventures II GP, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 AH Equity Partners Bio I, L.L.C. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 5AM Partners VI, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Maricich Yuri Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Mandel-Brehm Josh CEO Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Gold Kelly CFO Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Nashat Amir Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Schwab Andrew J. Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Bumcrot David Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Holtzman Steven H Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Chakravarty Ingo Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Higgins Michael J Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Ragan Paula Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Thadhani Ravi I. Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Young Richard A Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Boylan James P Director Neutral 52.5 - 0.00% ✗ -